JPTXF yields 1.29% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, JPTXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JPTXF + PFE for your $10,000?
Japan Petroleum Exploration Co., Ltd., together with its subsidiaries, explores for, develops, produces, and sells oil, natural gas, and other energy resources in Japan and internationally. The company operates 10 domestic oil and natural gas fields in onshore and offshore of Hokkaido, Akita, Yamagata, and Niigata prefectures. It also owns and manages a natural gas pipeline network with a total length of approximately 800 kilometres. In addition, the company is involved in well drilling and engineering contracting business; manufacturing and selling oil products; real estate management and insurance agency activities; sale and contracted transportation of crude oil; recycling of waste oil; and pipeline management and maintenance operations. Further, it engages in the geophysical exploration work contracting and geophysical exploration technology development; geophysical logging and mud logging work contract; exploration, development, and production of tight oil, oil sands, and shale gas; purchase and sale of LNG, petroleum products, etc.; provision of industrial disaster prevention and security services; development of solar, wind, geothermal, biomass, and other renewable energy sources; supply of electric power; manufacture and sale of drilling mud preparations and mud; and operation and commissioning of natural power plants. The company was founded in 1955 and is headquartered in Tokyo, Japan.
Full JPTXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.